Dr. Lifshitz is an experienced microbiologist with a proven track record managing early stage research and development programs in the area of anti-microbial therapeutics. At Trobix Ziv heads our R&D.
Prior to joining Trobix Bio, Ziv served as a senior scientist at Zolex Ltd., where he led the development steps from hit screening and characterization to demonstrate efficacy in preclinical studies. Previously, Ziv served as research investigator in the Division of Infectious Diseases at Tel Aviv Sourasky Medical Center. There, he led clinical research of antibiotic-resistant bacteria, mechanisms of infection and routes of dissemination. Ziv attained deep scientific understanding using the implementation of next generation sequencing (NGS) technology and became an expert in investigating the in-vivo pathogenesis of various infectious agents using different animal models.
Ziv holds a PhD from Tel Aviv University where he investigated the molecular pathogenesis mechanisms of the human pathogen Legionella Pneumophila.